COST-BENEFIT AND COST-EFFECTIVENESS - METHODOLOGIES FOR EVALUATING INNOVATIVE PHARMACEUTICAL SERVICES

被引：34
|
作者：
MCGHAN, WF
ROWLAND, CR
BOOTMAN, JL
机构：
来源：
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1978年 / 35卷 / 02期
关键词：
D O I：
10.1093/ajhp/35.2.133
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：133 / 140
页数：8
相关论文
共 50 条
  • [41] A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada
    Ehsan Jozaghi
    Andrew A Reid
    Martin A Andresen
    Substance Abuse Treatment, Prevention, and Policy, 8
  • [42] Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?
    Dolan, P
    Edlin, R
    JOURNAL OF HEALTH ECONOMICS, 2002, 21 (05) : 827 - 843
  • [43] A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada
    Ehsan Jozaghi
    Andrew A Reid
    Martin A Andresen
    Alexandre Juneau
    Substance Abuse Treatment, Prevention, and Policy, 9
  • [44] Cost-effectiveness and cost-benefit of worksite health promotion programs in Europe: a systematic review
    Lutz, Nathanael
    Taeymans, Jan
    Ballmer, Claudia
    Verhaeghe, Nick
    Clarys, Peter
    Deliens, Tom
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29 (03): : 540 - 546
  • [45] Cost-effectiveness and cost-benefit analyses of fluoride varnish for caries prevention in Guangxi, China
    Tang, Liying
    Nong, Shengjie
    Chen, Kun
    Liu, Qiulin
    Yu, Xueting
    Zeng, Xiaojuan
    BMC ORAL HEALTH, 2024, 24 (01)
  • [46] A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada
    Jozaghi, Ehsan
    Reid, Andrew A.
    Andresen, Martin A.
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2013, 8
  • [47] COST-BENEFIT AND COST-EFFECTIVENESS ANALYSIS IN HEALTH-CARE - GROWTH AND COMPOSITION OF THE LITERATURE
    WARNER, KE
    HUTTON, RC
    MEDICAL CARE, 1980, 18 (11) : 1069 - 1084
  • [48] Nosocomial respiratory syncytial virus infections: The cost-effectiveness and cost-benefit of infection control
    Macartney, KK
    Gorelick, MH
    Manning, ML
    Hodinka, RL
    Bell, LM
    PEDIATRICS, 2000, 106 (03) : 520 - 526
  • [49] A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada
    Jozaghi, Ehsan
    Reid, Andrew A.
    Andresen, Martin A.
    Juneau, Alexandre
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2014, 9
  • [50] COST-BENEFIT AND COST-EFFECTIVENESS ANALYSIS OF HOME ARTIFICIAL NUTRITION - REAPPRAISAL OF AVAILABLE DATA
    PIRONI, L
    TOGNONI, G
    CLINICAL NUTRITION, 1995, 14 : 87 - 91
12345